CLASS II Drug recall · Reported 28 Sep 2016 · FDA Enforcement Report

Phenylephrine HCI Injection, USP, 10mg/mL recalled by Sandoz

Sandoz is recalling Phenylephrine HCI Injection, USP, 10mg/mL, distributed nationwide in the US. The recall was initiated on 24 Aug 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) 091914, Exp 09/16; b) 080114, Exp 08/16; 090414, 092614, Exp 09/16
Quantity recalleda) 1,584 cartons; b) 62,170 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1514-2016
FDA event ID
75032
Recalling firm
Sandoz, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
24 Aug 2016
FDA classified
19 Sep 2016
Reported
28 Sep 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

24 Aug 2016Recall initiated by company
19 Sep 2016Classified by FDA+26 days
28 Sep 2016Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Which lots are affected?

Lot #: a) 091914, Exp 09/16; b) 080114, Exp 08/16; 090414, 092614, Exp 09/16

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 75032
ReportedClassRecallCompanyReasonWhere
CLASS IIEphedrine Sulfate Injection, USP, 50 mg/mL Fill in a Vial recalledSandozSterilityNationwide

More recalls from Sandoz

All 59

Other Phenylephrine Hci recalls

All 3